Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

Rosario.jpg

Rosario Isasi, J.D., M.P.H., is a Research Assistant Professor at the Dr. John T. Macdonald Foundation Department of Human Genetics at the University of Miami Miller School of Medicine. She holds multiple appointments, including at the John P. Hussman Institute for Human Genomics and the Interdisciplinary Stem Cell Institute. 

Prof. Isasi’s research is devoted to identifying and analyzing the social, ethical and policy dimensions of novel and disruptive genetic technologies, such as gene editing and synthetic biology. She has built an international reputation as a scholar with particular expertise in the area of international comparative law and ethics regarding genomics and regenerative medicine. 

She holds many leadership roles in major international initiatives. Since 2017, Prof.  Isasi has been appointed as the President’s International Fellow of the Chinese Academy of Sciences (CAS) and Adjunct Professor at the CAS’ Institute of Zoology. She is Co-Investigator and Ethics/Regulatory/Communications lead for the SouthEast Enrollment Center (SEEC) a consortium member of the NIH’s All of Us Research Program. She also serves as the co-Chair of the All of Us’ Resource Access Board.  In addition, Mrs. Isasi is the Ethics/Policy Advisor of the European Commission’s European Human Pluripotent Stem Cell Registry (hPSCREG), a member of the American Society for Human Genetics (ASHG) Task Force on “Gene Editing”, of the Canadian Institutes for Health Research’s (CIHR) Stem Cell Oversight Committee (SCOC) and of the Ethics & Policy Committee of the International Society for Stem Cell Research (ISSCR). Finally, Professor Isasi Chairs the International Stem Cell Forum (ISCF) Ethics Working Party, a consortium of funding agencies for regenerative medicine.